Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 11 | $1,965,408 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 15 Oct 2024 17:30 | RVMD | Revolution Medicines Inc | ANDERS JACK | Chief Financial Officer | 11 Oct 2024 | Sale | 10,000 | 50.2979 | 502,979 | D |
| 18 Sep 2024 16:18 | RVMD | Revolution Medicines Inc | ANDERS JACK | Chief Financial Officer | 16 Sep 2024 | Sale | 2,244 | 44.1853 | 99,152 | D |
| 20 Jun 2024 16:13 | RVMD | Revolution Medicines Inc | ANDERS JACK | Chief Financial Officer | 17 Jun 2024 | Sale | 1,893 | 37.3876 | 70,775 | D |
| 03 May 2024 19:36 | RVMD | Revolution Medicines Inc | ANDERS JACK | Chief Financial Officer | 03 May 2024 | Sale | 10,000 | 40.026 | 400,260 | D |
| 20 Mar 2024 16:43 | RVMD | Revolution Medicines Inc | ANDERS JACK | Chief Financial Officer | 18 Mar 2024 | Sale | 1,261 | 31.5832 | 39,826 | D |
| 20 Dec 2023 17:10 | RVMD | Revolution Medicines Inc | ANDERS JACK | Chief Financial Officer | 18 Dec 2023 | Sale | 1,775 | 25.9018 | 45,976 | D |
| 20 Sep 2023 16:11 | RVMD | Revolution Medicines Inc | ANDERS JACK | Chief Financial Officer | 18 Sep 2023 | Sale | 1,427 | 31.3106 | 44,680 | D |
| 06 Sep 2023 20:02 | RVMD | Revolution Medicines Inc | ANDERS JACK | Chief Financial Officer | 01 Sep 2023 | Sale | 20,000 | 35.0546 | 701,092 | D |
| 22 Jun 2023 16:25 | RVMD | Revolution Medicines Inc | ANDERS JACK | Chief Financial Officer | 20 Jun 2023 | Sale | 1,249 | 24.891 | 31,089 | D |
| 21 Mar 2023 20:33 | RVMD | Revolution Medicines Inc | ANDERS JACK | Chief Financial Officer | 17 Mar 2023 | Sale | 665 | 21.78 | 14,484 | D |
| 21 Dec 2022 16:08 | RVMD | Revolution Medicines Inc | ANDERS JACK | Chief Financial Officer | 19 Dec 2022 | Sale | 658 | 22.9405 | 15,095 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)